George Markovich, MD
Orthopaedic Surgery · Fort Myers, FLNPI 1487655999
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $27,750 of the $32,974 with a category attached, or 84.2%. Encore Medical, LP accounts for 84.2% of it on its own, with 22 other manufacturers making up the rest.
Across 60 payments — averaging $549.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$28K
- Pacira Therapeutics, Inc.$3K
- Corin USA$1K
- Zimmer Biomet$789
- Si-bone, Inc.$75
- Conformis, Inc.$61
- plus $423 from 17 others
Across 4 payments — averaging $1067.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Encore Medical, LP$4K
What the payments were for
- Royalty or licence$27,75084%
- Consulting fees$1,0003%
- Speaking & faculty fees$2,8759%
- Travel & lodging$3941%
- Food & beverage$9553%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 11 | $27,750 |
| Pacira Therapeutics, Inc. | 1 | $2,875 |
| Corin USA | 1 | $1,000 |
| Zimmer Biomet | 25 | $789 |
| Si-bone, Inc. | 2 | $75 |
| Conformis, Inc. | 1 | $61 |
| Omnilife Science, Inc | 1 | $55 |
| ERMI LLC | 1 | $45 |
| Johnson & Johnson | 1 | $40 |
| Pfizer | 2 | $34 |
| SPR Therapeutics, Inc | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Vericel Corporation | 1 | $24 |
| Avanos Medical | 1 | $24 |
| Heraeus Medical, LLC. | 2 | $21 |
| Orthogenrx Inc. | 1 | $20 |
| DJO, LLC | 1 | $19 |
| MVP Orthopedics Inc | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Carbofix Orthopedics Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$111,002
- Zilretta$2,875
- Oxford$330
How this compares
$32,974 in reported general payments places this provider in the 80th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 110 | $621 |
| Meloxicam | 56 | $169 |
| Amoxicillin | 17 | $17 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fort Myers
- William HodgeFort Myers$1.1M
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.